BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barthelmes L, Tait IS. Liver cell adenoma and liver cell adenomatosis. HPB (Oxford). 2005;7:186-196. [PMID: 18333188 DOI: 10.1080/13651820510028954] [Cited by in Crossref: 86] [Cited by in F6Publishing: 66] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Karkar AM, Tang LH, Kashikar ND, Gonen M, Solomon SB, Dematteo RP, D’ Angelica MI, Correa-Gallego C, Jarnagin WR, Fong Y. Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB (Oxford). 2013;15:235-243. [PMID: 23374365 DOI: 10.1111/j.1477-2574.2012.00584.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
2 Glinka J, Clariá RS, Fratanoni E, Spina J, Mullen E, Ardiles V, Mazza O, Pekolj J, de Santibañes M, de Santibañes E. Malignant transformation of hepatocellular adenoma in a young female patient after ovulation induction fertility treatment: A case report. World J Gastrointestinal Surgery 2019; 11(4): 229-236 [PMID: 31123560 DOI: 10.4240/wjgs.v11.i4.229] [Reference Citation Analysis]
3 Oji K, Urade T, Iwatani Y, Tanaka K, Hirano H, Sanuki T, Tomita M, Yamamoto Y, Zen Y, Kuroda D. Case of resected multiple hepatocellular adenomas in a young man with severe obesity. Surg Case Rep 2019;5:131. [PMID: 31410698 DOI: 10.1186/s40792-019-0689-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kaltenbach TE, Engler P, Kratzer W, Oeztuerk S, Seufferlein T, Haenle MM, Graeter T. Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol (NY). 2016;41:25-32. [PMID: 26830608 DOI: 10.1007/s00261-015-0605-7] [Cited by in Crossref: 61] [Cited by in F6Publishing: 45] [Article Influence: 12.2] [Reference Citation Analysis]
5 Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12:509-522. [PMID: 20887318 DOI: 10.1111/j.1477-2574.2010.00222.x] [Cited by in Crossref: 212] [Cited by in F6Publishing: 183] [Article Influence: 21.2] [Reference Citation Analysis]
6 Roncalli M, Sciarra A, Tommaso LD. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin Mol Hepatol 2016;22:199-211. [PMID: 27189732 DOI: 10.3350/cmh.2016.0101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
7 Glockner JF, Lee CU, Mounajjed T. Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents. Magn Reson Imaging 2018;47:103-10. [PMID: 29221964 DOI: 10.1016/j.mri.2017.12.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
8 Shao N, Pandey A, Ghasabeh MA, Khoshpouri P, Pandey P, Varzaneh FN, Zarghampour M, Fouladi D, Pawlik TM, Anders RA, Kamel IR. Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation. Clin Radiol 2018;73:958-65. [PMID: 30031588 DOI: 10.1016/j.crad.2018.06.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
9 Manichon AF, Bancel B, Durieux-Millon M, Ducerf C, Mabrut JY, Lepogam MA, Rode A. Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions. HPB Surg 2012;2012:418745. [PMID: 22811588 DOI: 10.1155/2012/418745] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
10 Liu H, Zhao Q, Jin G, Qian Y, Gu Y, Dong H, Lu X, Cong W, Wu M. Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population. Pathology - Research and Practice 2015;211:918-24. [DOI: 10.1016/j.prp.2015.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Walther Z, Jain D. Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int. 2011;2011:403929. [PMID: 21559202 DOI: 10.4061/2011/403929] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
12 Muranushi R, Araki K, Harimoto N, Yokobori T, Hoshino K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Aishima S, Shirabe K. Unclassified hepatocellular adenoma with beta-catenin mutation: a case report. Surg Case Rep 2021;7:46. [PMID: 33580445 DOI: 10.1186/s40792-021-01131-9] [Reference Citation Analysis]
13 Shanbhogue A, Shah SN, Zaheer A, Prasad SR, Takahashi N, Vikram R. Hepatocellular adenomas: current update on genetics, taxonomy, and management. J Comput Assist Tomogr. 2011;35:159-166. [PMID: 21412084 DOI: 10.1097/RCT.0b013e31820bad61] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
14 Grieser C, Steffen IG, Kramme IB, Bläker H, Kilic E, Perez Fernandez CM, Seehofer D, Schott E, Hamm B, Denecke T. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 2014;24:1339-48. [PMID: 24658870 DOI: 10.1007/s00330-014-3144-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
15 Dardenne S, Hubert C, Sempoux C, Annet L, Jouret-Mourin A, Horsmans Y, Van Beers BE, Zech F, Gigot JF. Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm. Eur J Gastroenterol Hepatol. 2010;22:1337-1344. [PMID: 20683192 DOI: 10.1097/MEG.0b013e32833db907] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Di Sandro S, Slim AO, Lauterio A, Giacomoni A, Mangoni I, Aseni P, Pirotta V, Aldumour A, Mihaylov P, De Carlis L. Liver adenomatosis: a rare indication for living donor liver transplantation. Transplant Proc. 2009;41:1375-1377. [PMID: 19460563 DOI: 10.1016/j.transproceed.2009.03.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
17 Thiesen AL. Hepatocellular Carcinoma in Adults. In: Sergi CM, editor. Liver Cancer. Exon Publications; 2021. pp. 39-54. [DOI: 10.36255/exonpublications.livercancer.2021.ch2] [Reference Citation Analysis]
18 Paradis V. Benign Liver Tumors: An update. Clinics in Liver Disease 2010;14:719-29. [DOI: 10.1016/j.cld.2010.07.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
19 Grieser C, Steffen IG, Seehofer D, Kramme I, Uktolseya R, Scheurig-muenkler C, Hamm B, Denecke T. Histopathologically confirmed focal nodular hyperplasia of the liver: Gadoxetic acid-enhanced MRI characteristics. Magnetic Resonance Imaging 2013;31:755-60. [DOI: 10.1016/j.mri.2012.11.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
20 Liu W, Delwaide J, Bletard N, Delvenne P, Meunier P, Hustinx R, Detry O. 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report. World J Hepatol 2017; 9(11): 562-566 [PMID: 28469812 DOI: 10.4254/wjh.v9.i11.562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Thomeer MG, Broker M, Verheij J, Doukas M, Terkivatan T, Bijdevaate D, De Man RA, Moelker A, IJzermans JN. Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol. 2016;9:898-912. [PMID: 27803743 DOI: 10.1177/1756283x16663882] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 5.8] [Reference Citation Analysis]
22 Cristiano A, Dietrich A, Spina JC, Ardiles V, de Santibañes E. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg 2014;66:9-21. [DOI: 10.1007/s13304-013-0222-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
23 Agostini-vulaj D, Sharma AK, Findeis-hosey JJ, Mcmahon LA, Gonzalez RS. Distinction between inflammatory hepatocellular adenoma and mass effect on liver sampling. Human Pathology 2017;61:105-10. [DOI: 10.1016/j.humpath.2016.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
24 Sakamoto A, Hayashi H, Sakamoto I, Isomoto I, Eguchi S, Takatsuki M, Kanematsu T, Abe K, Hayashi T, Uetani M. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA. Abdom Imaging. 2012;37:239-243. [PMID: 21416130 DOI: 10.1007/s00261-011-9721-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
25 Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137:1698-1705. [PMID: 19664629 DOI: 10.1053/j.gastro.2009.07.061] [Cited by in Crossref: 266] [Cited by in F6Publishing: 199] [Article Influence: 22.2] [Reference Citation Analysis]
26 Baheti AD, Yeh MM, O'Malley R, Lalwani N. Malignant Transformation of Hepatic Adenoma in Glycogen Storage Disease Type-1a: Report of an Exceptional Case Diagnosed on Surveillance Imaging. J Clin Imaging Sci. 2015;5:47. [PMID: 26430540 DOI: 10.4103/2156-7514.163991] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
27 de'Angelis N, Memeo R, Calderaro J, Felli E, Salloum C, Compagnon P, Luciani A, Laurent A, Cherqui D, Azoulay D. Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford). 2014;16:783-788. [PMID: 24852081 DOI: 10.1111/hpb.12257] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
28 McInnes MD, Hibbert RM, Inácio JR, Schieda N. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review. Radiology 2015;277:413-23. [PMID: 26020440 DOI: 10.1148/radiol.2015142986] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 9.3] [Reference Citation Analysis]
29 Lin H, van den Esschert J, Liu C, van Gulik TM. Systematic review of hepatocellular adenoma in China and other regions: Hepatocellular adenoma review. Journal of Gastroenterology and Hepatology 2011;26:28-35. [DOI: 10.1111/j.1440-1746.2010.06502.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
30 Gurzu S, Jung I, Contac AO, Turcu M, Tudor A. Atypical Hepatocellular Neoplasm With Peliosis in Cirrhotic Liver Versus Hepatocellular Carcinoma: A Diagnostic Trap. Medicine (Baltimore) 2015;94:e1189. [PMID: 26200629 DOI: 10.1097/MD.0000000000001189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Montenovo MI, Jalikis FG, Yeh M, Reyes JD. Progression of Hepatic Adenoma to Carcinoma in the Setting of Hepatoportal Sclerosis in HIV Patient: Case Report and Review of the Literature. Case Reports Hepatol 2016;2016:1732069. [PMID: 27812395 DOI: 10.1155/2016/1732069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Seo JM, Lee SJ, Kim SH, Park CK, Ha SY. Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver. Clin Radiol. 2012;67:329-333. [PMID: 22079485 DOI: 10.1016/j.crad.2011.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
33 Marín Camero N, Fernández Aguilar JL, Sánchez Pérez B, Suárez Muñoz MÁ, Santoyo Santoyo J. De la hiperplasia nodular focal al adenoma inflamatorio hepático. Cirugía Española 2012;90:200-1. [DOI: 10.1016/j.ciresp.2010.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Donato M, Hamidian Jahromi A, Andrade AI, Kim R, Chaudhery SI, Sangster G. Hepatic adenomatosis: a rare but important liver disease with severe clinical implications. Int Surg 2015;100:903-7. [PMID: 26011213 DOI: 10.9738/INTSURG-D-14-00161.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 156] [Article Influence: 99.0] [Reference Citation Analysis]
36 Caruso S, Mamone G, Marrone G, Milazzo M, Carollo V, Miraglia R, Maruzzelli L, Pasta A, Minervini MI, Spada M, Riva S, Luca A, Gridelli B. Focal liver diseases in neonatal and pediatric liver transplant candidates: a pictorial essay. Clin Transplant 2010;24:592-8. [PMID: 19888996 DOI: 10.1111/j.1399-0012.2009.01139.x] [Reference Citation Analysis]
37 van Aalten SM, Witjes CD, de Man RA, Ijzermans JN, Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int. 2012;32:28-37. [PMID: 22098685 DOI: 10.1111/j.1478-3231.2011.02667.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
38 Bioulac-Sage P, Laumonier H, Sa Cunha A, Balabaud C. Hepatocellular adenomas. Liver Int. 2009;29:142. [PMID: 18828785 DOI: 10.1111/j.1478-3231.2008.01884.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
39 Taj H, Comba I, Kumar S, Lakhinder B. Extracapsular Hepatocellular Adenoma: A Diagnostic Dilemma. Cureus 2020;12:e8928. [PMID: 32760628 DOI: 10.7759/cureus.8928] [Reference Citation Analysis]
40 Deodhar A, Brody LA, Covey AM, Brown KT, Getrajdman GI. Bland embolization in the treatment of hepatic adenomas: preliminary experience. J Vasc Interv Radiol 2011;22:795-9; quiz 800. [PMID: 21616432 DOI: 10.1016/j.jvir.2011.02.027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
41 Marín Hernández C, Robles Campos R, López Conesa A, Parrilla P. Adenomatosis hepática múltiple tratada con resección quirúrgica y radiofrecuencia. Cirugía Española 2010;88:337-8. [DOI: 10.1016/j.ciresp.2009.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Cedillo MA, Wong J, Song JW, Liao J. A rare case of hepatocellular carcinoma arising from gadoxetate-retaining hepatic adenoma. Radiol Case Rep 2020;15:141-3. [PMID: 31827660 DOI: 10.1016/j.radcr.2019.10.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Haddouche A, Bellanne-Chantelot C, Rod A, Fournier L, Chiche L, Gautier JF, Timsit J, Laboureau S, Chaillous L, Valero R, Larger E, Jeandidier N, Wilhelm JM, Popelier M, Guillausseau PJ, Thivolet C, Lecomte P, Benhamou PY, Reznik Y. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series. J Diabetes 2020;12:48-57. [PMID: 31166087 DOI: 10.1111/1753-0407.12959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Thapar M, Grapp O, Fisher C. Management of hepatic adenomatosis. Curr Gastroenterol Rep 2015;17:12. [PMID: 25740249 DOI: 10.1007/s11894-015-0434-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Burgis JC, Pratt CA, Higgins JP, Kerner JA. Multiple hepatic adenomas in a child with microvillus inclusion disease. Dig Dis Sci. 2013;58:2784-2788. [PMID: 23525737 DOI: 10.1007/s10620-013-2646-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
46 Landi F, De' Angelis N, Scatton O, Vidal X, Ayav A, Muscari F, Dokmak S, Torzilli G, Demartines N, Soubrane O, Cherqui D, Hardwigsen J, Laurent A. Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group. Surg Endosc 2017;31:4136-44. [PMID: 28281121 DOI: 10.1007/s00464-017-5466-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
47 Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, Gamblin TC. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15:2795-2803. [PMID: 18696154 DOI: 10.1245/s10434-008-0090-0] [Cited by in Crossref: 101] [Cited by in F6Publishing: 79] [Article Influence: 7.8] [Reference Citation Analysis]
48 Di Carlo I, Pulvirenti E, Toro A, Priolo GD. Adenoma or atypical hepatic focal nodular hyperplasia: role of preoperative imaging and laparoscopic treatment. Surg Laparosc Endosc Percutan Tech 2010;20:e105-9. [PMID: 20551788 DOI: 10.1097/SLE.0b013e3181e0b2e6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
49 Belghiti J, Dokmak S, Vilgrain V, Paradis V. Benign liver lesions. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Elsevier; 2012. pp. 1250-1267.e4. [DOI: 10.1016/b978-1-4377-1454-8.00079-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
50 Fodor M, Primavesi F, Braunwarth E, Cardini B, Resch T, Bale R, Putzer D, Henninger B, Oberhuber R, Maglione M, Margreiter C, Schneeberger S, Öfner D, Stättner S. Indications for liver surgery in benign tumours. Eur Surg 2018;50:125-31. [PMID: 29875801 DOI: 10.1007/s10353-018-0536-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
51 Hilal MA, Fabio FD, Wiltshire RD, Hamdan M, Layfield DM, Pearce NW. Laparoscopic liver resection for hepatocellular adenoma. World J Gastrointest Surg 2011; 3(7): 101-105 [PMID: 21860698 DOI: 10.4240/wjgs.v3.i7.101] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
52 Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Ventura A. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. PLoS One 2018;13:e0200776. [PMID: 30052636 DOI: 10.1371/journal.pone.0200776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
53 Denecke T, Steffen IG, Agarwal S, Seehofer D, Kröncke T, Hänninen EL, Kramme IB, Neuhaus P, Saini S, Hamm B. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol. 2012;22:1769-1775. [PMID: 22437921 DOI: 10.1007/s00330-012-2422-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
54 Pulvirenti E, Toro A, Di Carlo I. An update on indications for treatment of solid hepatic neoplasms in noncirrhotic liver. Future Oncology 2010;6:1243-50. [DOI: 10.2217/fon.10.85] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
55 van Rosmalen BV, Klompenhouwer AJ, de Graeff JJ, Haring MPD, de Meijer VE, Rifai L, Dokmak S, Rawashdeh A, Abu Hilal M, de Jong MC, Dejong CHC, Doukas M, de Man RA, IJzermans JNM, van Delden OM, Verheij J, van Gulik TM; Dutch Benign Liver Tumour Group. Safety and efficacy of transarterial embolization of hepatocellular adenomas. Br J Surg 2019;106:1362-71. [PMID: 31313827 DOI: 10.1002/bjs.11213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
56 Cheng L, Liu Y, Wang W, Merritt JL, Yeh M. Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency. Case Reports Hepatol 2019;2019:2313791. [PMID: 31662921 DOI: 10.1155/2019/2313791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Jiang K, Al-Diffhala S, Centeno BA. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification. Cancer Control. 2018;25:1073274817744625. [PMID: 29350068 DOI: 10.1177/1073274817744625] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
58 Dumortier J, Guillaud O, Walter T, Ber CE, Partensky C, Boillot O, Scoazec JY. Liver transplantation for multiple angiomyolipomas complicating tuberous sclerosis complex. Gastroenterol Clin Biol 2010;34:494-8. [PMID: 20674202 DOI: 10.1016/j.gcb.2010.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
59 Park HJ, Byun JH, Kang JH, Kang HJ, Yu E, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma. Eur J Radiol 2021;139:109730. [PMID: 33930719 DOI: 10.1016/j.ejrad.2021.109730] [Reference Citation Analysis]
60 Vennarecci G, Santoro R, Antonini M, Ceribelli C, Laurenzi A, Moroni E, Burocchi M, Lepiane P, Ettorre GM. Liver transplantation for recurrent hepatic adenoma. World J Hepatol 2013; 5(3): 145-148 [PMID: 23556048 DOI: 10.4254/wjh.v5.i3.145] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
61 Dokmak S, Aussilhou B, Rasoaherinomenjanahary F, Ronot M, Dahdouh R, Ftériche FS, Cauchy F, Paradis V, Belghiti J, Soubrane O. Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery. HPB (Oxford) 2018;20:1198-205. [PMID: 31217088 DOI: 10.1016/j.hpb.2018.06.1796] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
62 Paradis V. Hepatocellular Adenomas. Surgical Pathology Clinics 2013;6:311-31. [DOI: 10.1016/j.path.2013.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Vijay A, Elaffandi A, Khalaf H. Hepatocellular adenoma: An update. World J Hepatol 2015; 7(25): 2603-2609 [PMID: 26557953 DOI: 10.4254/wjh.v7.i25.2603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
64 Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H, Zucman-Rossi J, Balabaud C, Saric J. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50:481-9. [PMID: 19585623 DOI: 10.1002/hep.22995] [Cited by in Crossref: 317] [Cited by in F6Publishing: 233] [Article Influence: 26.4] [Reference Citation Analysis]
65 Mironov O, Jaberi A, Beecroft R, Kachura JR. Retrospective Single-Arm Cohort Study of Patients with Hepatocellular Adenomas Treated with Percutaneous Thermal Ablation. Cardiovasc Intervent Radiol 2018;41:935-41. [DOI: 10.1007/s00270-018-1893-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
66 Auer TA, Walter-Rittel T, Geisel D, Schöning W, Schmelzle M, Müller T, Sinn B, Denecke T, Hamm B, Fehrenbach U. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. BMC Med Imaging 2021;21:28. [PMID: 33588783 DOI: 10.1186/s12880-021-00552-0] [Reference Citation Analysis]